Trial intelligence / Profile preview

Nitrone for Injection in Acute Ischemic Stroke

NCT04951440Unknown

Sponsor
Peking University Third Hospital
Start
Jun 2018
Primary completion
Dec 2020
Countries
1
01

Overview

Randomised, double-blind trial in ischemic stroke (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: National Institutes of Health Stroke Scale Response at 14 days. Status: unknown.

02

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04951440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04951440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call